IMLYGIC sol inj 1 mio UFP/ml flac 1 ml
7680658120010
CH-65812
L01XL02
07.16.
Reimbursement limitations:
IMLYGIC2
IMLYGIC est pris en charge en monothérapie, pour le traitement locale de première intention des …
1 / 3
google
Details
- Product number
- 6581201
- CPT
- -
- Packaging group
- 1 ml
- Unit
- Durchstechflasche(n)
- Composition
- Lösung: talimogenum laherparepvecum 1 Million U..
Articles (1)
Imlygic 10e6, Injektionslösung
Injektionslösung
1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLU
|
- | Substance | Wirkstoff (Principe actif) |
Reimbursement information
Public price
CHF 2233.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2017
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 65812
- Drug name
- Imlygic, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- L01XL02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/07/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IMLYGIC sol inj 1 mio UFP/ml flac 1 ml
- Description (DE)
- IMLYGIC Inj Lös 1 Mio PFU/ml Durchstf 1 ml
- Market launch
- 13/07/2016
- Narcotic (BTM)
- No
Application methods
ILES